SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Outsourced research and development (R&D) has become central to how pharmaceutical and biotechnology companies manage innovation, scale, and cost. As pipelines expand and modalities become more complex, sponsors increasingly rely on external partners to deliver discovery, development, and manufacturing activities at pace. At the same time, regulatory expectations around GXP compliance continue to intensify. This […]
